These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16480775

  • 1. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.
    Volz TJ, Hanson GR, Fleckenstein AE.
    J Neurosci Methods; 2006 Jul 15; 155(1):109-15. PubMed ID: 16480775
    [Abstract] [Full Text] [Related]

  • 2. Bupropion increases striatal vesicular monoamine transport.
    Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE.
    Neuropharmacology; 2005 Nov 15; 49(6):820-30. PubMed ID: 16005476
    [Abstract] [Full Text] [Related]

  • 3. Kinetic analysis of developmental changes in vesicular monoamine transporter-2 function.
    Volz TJ, Hanson GR, Fleckenstein AE.
    Synapse; 2006 Nov 15; 60(6):474-7. PubMed ID: 16897727
    [Abstract] [Full Text] [Related]

  • 4. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.
    Volz TJ, Farnsworth SJ, King JL, Riddle EL, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2007 Nov 15; 323(2):738-45. PubMed ID: 17693585
    [Abstract] [Full Text] [Related]

  • 5. Extracting the basal extracellular dopamine concentrations from the evoked responses: re-analysis of the dopamine kinetics.
    Chen KC, Budygin EA.
    J Neurosci Methods; 2007 Aug 15; 164(1):27-42. PubMed ID: 17498808
    [Abstract] [Full Text] [Related]

  • 6. Measurement of plasmalemmal dopamine transport, vesicular dopamine transport, and K(+)-stimulated dopamine release in frozen rat brain tissue.
    Volz TJ, Farnsworth SJ, Hanson GR, Fleckenstein AE.
    J Neurosci Methods; 2009 Jun 15; 180(2):317-20. PubMed ID: 19464519
    [Abstract] [Full Text] [Related]

  • 7. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits.
    Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2003 Mar 15; 304(3):1181-7. PubMed ID: 12604695
    [Abstract] [Full Text] [Related]

  • 8. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Mar 15; 296(3):762-7. PubMed ID: 11181904
    [Abstract] [Full Text] [Related]

  • 9. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.
    Truong JG, Hanson GR, Fleckenstein AE.
    Eur J Pharmacol; 2004 May 25; 492(2-3):143-7. PubMed ID: 15178358
    [Abstract] [Full Text] [Related]

  • 10. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L, Crooks PA, Sonsalla PK, Dwoskin LP.
    J Pharmacol Exp Ther; 1997 Mar 25; 280(3):1432-44. PubMed ID: 9067333
    [Abstract] [Full Text] [Related]

  • 11. Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles.
    Volz TJ, Farnsworth SJ, Hanson GR, Fleckenstein AE.
    J Neurosci Methods; 2009 Feb 15; 177(1):177-82. PubMed ID: 18992277
    [Abstract] [Full Text] [Related]

  • 12. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ, Yamamoto BK.
    J Pharmacol Exp Ther; 2005 Jan 15; 312(1):160-9. PubMed ID: 15331654
    [Abstract] [Full Text] [Related]

  • 13. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.
    Truong JG, Wilkins DG, Baudys J, Crouch DJ, Johnson-Davis KL, Gibb JW, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2005 Sep 15; 314(3):1087-92. PubMed ID: 15901804
    [Abstract] [Full Text] [Related]

  • 14. Testosterone modulation of striatal dopamine output in orchidectomized mice.
    Shemisa K, Kunnathur V, Liu B, Salvaterra TJ, Dluzen DE.
    Synapse; 2006 Oct 15; 60(5):347-53. PubMed ID: 16838357
    [Abstract] [Full Text] [Related]

  • 15. Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice.
    Ji J, McDermott JL, Dluzen DE.
    J Neuroendocrinol; 2007 Sep 15; 19(9):725-31. PubMed ID: 17680888
    [Abstract] [Full Text] [Related]

  • 16. PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content.
    Bemis JC, Seegal RF.
    Toxicol Sci; 2004 Aug 15; 80(2):288-95. PubMed ID: 15115888
    [Abstract] [Full Text] [Related]

  • 17. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
    Andersson DR, Nissbrandt H, Bergquist F.
    Eur J Neurosci; 2006 Jul 15; 24(2):617-24. PubMed ID: 16903863
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.
    Truong JG, Newman AH, Hanson GR, Fleckenstein AE.
    Eur J Pharmacol; 2004 Nov 03; 504(1-2):27-32. PubMed ID: 15507217
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms by which amphetamine redistributes dopamine out of vesicles: a computational study.
    Wallace LJ, Connell LE.
    Synapse; 2008 May 03; 62(5):370-8. PubMed ID: 18297690
    [Abstract] [Full Text] [Related]

  • 20. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
    Wilhelm CJ, Johnson RA, Lysko PG, Eshleman AJ, Janowsky A.
    J Pharmacol Exp Ther; 2004 Sep 03; 310(3):1142-51. PubMed ID: 15102929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.